Alergia e intolerancia a antiinflamatorios no esteroides: desensibilización exitosa en tres casos y revisión de la literatura
Palabras clave:
hipersensibilidad a los medicamentos, aspirina, agentes antiinflamatorios no esteroides, desensibilización inmunológica, asma, anafilaxis, pólipos nasales, sinusitis
Resumen
Los antiinflamatorios no esteroides son la segunda causa de reacciones a medicamentos después de los beta-lactámicos. La prevalencia de las reacciones a antiinflamatorios no esteroideos en la población general es de 0,1% a 0,3% y la prevalencia de anafilaxia inducida por ellos es de 0,01%.La intolerancia al ácido acetilsalicílico o a los antiinflamatorios no esteroides se presenta con síntomas como urticaria aguda, angioedema, crisis asmática, enfermedad respiratoria exacerbada por ácido acetilsalicílico y anafilaxia.
Presentamos una revisión actualizada basada en tres casos de pacientes con intolerancia al ácido acetilsalicílico o a los antiinflamatorios no esteroideos que, por sus enfermedades concomitantes, requerían tratamiento permanente conácido acetilsalicílico. Después de someterlos a un protocolo de desensibilización rápida ácido acetilsalicílico en una unidad de cuidados intensivos, estos pacientes pudieron continuar recibiendo ácido acetilsalicílico diariamente sin efectos adversos.
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. Demoly P, Hillaire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am. 2004;24:345-56.
2. Sánchez-Borges M. Clinical management of nonsteroidal anti-inflammatory drug hypersensitivity. WAO Journal. 2008;1:29-33.
3. Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13-21.
4. Cianferoni A, Novembre E, Mugnaini L, Lombardi E, Bernardini R, Pucci N, et al. Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). Ann Allergy Asthma Immunol. 2001;87:27-32.
5. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-21.
6. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986;314:1589-92.
7. Settipane GA. Aspirin and allergic diseases: a review. Am J Med. 1983;74:102-9.
8. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol. 2002;3:599-607.
9. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol. 2006;6:476-81.
10. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180-6.
11. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017-23.
12. Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med. 1922;30:189-92.
13. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85:59-65.
14. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98:751-8.
15. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent impro-vements. Curr Opin Allergy Clin Immunol. 2006;6:161-6.
16. White AA, Stevenson DD, Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2005;95:330-5.
17. Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol. 2006;118:801-4.
18. Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509-10.
19. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. The multiple faces of nonsteroidal antiinflammatory drug hypersensitivity. J Investig Allergol Clin Immunol. 2004;14:329-34.
20. Stevenson DD. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am. 2004;24:491-505.
21. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Reborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813-24.
22. Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy. 1994;72:29-32.
23. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy. 1998;53:1231-3.
24. Nettis E, Di Paola R, Ferrannini A, Tursi A. Meloxicam in hypersensitivity to NSAIDs. Allergy. 2001;56:803-4.
25. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol. 1996;98:678-85.
26. Ruxrungtham K, Chantaphakul H, Tiyasatapon S, Phanupak P. Acetaminophen cross-sensitivity is common in Thai patients with aspirin/NSAIDs Sensitivity and may be life-threatening. J Allergy Clin Immunol. 2002;109:s141.
27. Zedlitz S, Linzbach L, Kaufmann R, Boehncke WH. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing. Contact Derm. 2002;46:352-3.
28. Talhari C, Lauceviciute I, Enderlein E, Ruzicka T, Homey B. COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions. J Allergy Clin Immunol. 2005;115:1089-90.
29. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809-20.
30. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol. 1998;101:581-6.
31. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62:1111-8.
2. Sánchez-Borges M. Clinical management of nonsteroidal anti-inflammatory drug hypersensitivity. WAO Journal. 2008;1:29-33.
3. Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13-21.
4. Cianferoni A, Novembre E, Mugnaini L, Lombardi E, Bernardini R, Pucci N, et al. Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). Ann Allergy Asthma Immunol. 2001;87:27-32.
5. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-21.
6. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986;314:1589-92.
7. Settipane GA. Aspirin and allergic diseases: a review. Am J Med. 1983;74:102-9.
8. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol. 2002;3:599-607.
9. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol. 2006;6:476-81.
10. Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180-6.
11. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017-23.
12. Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med. 1922;30:189-92.
13. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85:59-65.
14. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98:751-8.
15. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent impro-vements. Curr Opin Allergy Clin Immunol. 2006;6:161-6.
16. White AA, Stevenson DD, Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2005;95:330-5.
17. Stevenson DD, Simon RA. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol. 2006;118:801-4.
18. Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509-10.
19. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. The multiple faces of nonsteroidal antiinflammatory drug hypersensitivity. J Investig Allergol Clin Immunol. 2004;14:329-34.
20. Stevenson DD. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am. 2004;24:491-505.
21. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Reborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813-24.
22. Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy. 1994;72:29-32.
23. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy. 1998;53:1231-3.
24. Nettis E, Di Paola R, Ferrannini A, Tursi A. Meloxicam in hypersensitivity to NSAIDs. Allergy. 2001;56:803-4.
25. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol. 1996;98:678-85.
26. Ruxrungtham K, Chantaphakul H, Tiyasatapon S, Phanupak P. Acetaminophen cross-sensitivity is common in Thai patients with aspirin/NSAIDs Sensitivity and may be life-threatening. J Allergy Clin Immunol. 2002;109:s141.
27. Zedlitz S, Linzbach L, Kaufmann R, Boehncke WH. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing. Contact Derm. 2002;46:352-3.
28. Talhari C, Lauceviciute I, Enderlein E, Ruzicka T, Homey B. COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions. J Allergy Clin Immunol. 2005;115:1089-90.
29. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809-20.
30. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol. 1998;101:581-6.
31. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62:1111-8.
Cómo citar
1.
Cardona R, Ramírez RH, Reina Z, Escobar MF, Morales E. Alergia e intolerancia a antiinflamatorios no esteroides: desensibilización exitosa en tres casos y revisión de la literatura. Biomed. [Internet]. 1 de junio de 2009 [citado 4 de abril de 2025];29(2):181-90. Disponible en: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/20
Algunos artículos similares:
- José Fernando Cantillo, Leonardo Puerta, Nuevos esquemas de inmunoterapia específicas con alérgenos , Biomédica: Vol. 30 Núm. 3 (2010)
- Astrid Berena Herrera, Laura A. Rodríguez, Jürg Niederbacher, Contaminación biológica intradomiciliaria y su relación con síntomas respiratorios indicativos de asma bronquial en preescolares de Bucaramanga, Colombia , Biomédica: Vol. 31 Núm. 3 (2011)
- Ángela M. Pedraza, Carlos E. Rodríguez-Martínez, Ranniery Acuña, Validación inicial de una escala para medir el nivel de sobrecarga de padres o cuidadores de niños asmáticos , Biomédica: Vol. 33 Núm. 3 (2013)
- Jairo Lizarazo, Edgar Parra, Patricia Gutiérrez, Carlos Mora, Juan Vargas, Paquimeningitis craneal hipertrófica idiopática. , Biomédica: Vol. 24 Núm. 2 (2004)
- Juan José Yepes-Núñez, Carolina Gómez, Yeinis Espinoza, Ricardo Cardona, Impacto de la inmunoterapia subcutánea con Dermatophagoides farinae y Dermatophagoides pteronyssinus sobre la calidad de vida de pacientes con rinitis y asma alérgica , Biomédica: Vol. 34 Núm. 2 (2014)
- Rodrigo Sarmiento, Luis Jorge Hernández, Edna Katalina Medina, Natalia Rodríguez, Jesús Reyes, Síntomas respiratorios asociados con la exposición a la contaminación del aire en cinco localidades de Bogotá, 2008-2011, estudio en una cohorte dinámica , Biomédica: Vol. 35 (2015): Agosto, Suplemento 2, Salud y contaminantes ambientales
- Jorge Sánchez, Susana Diez, Ricardo Cardona, Evitación de mascotas en casos de alergia. ¿Es factible lograrla? , Biomédica: Vol. 35 Núm. 3 (2015)
- Jorge Sánchez, Ricardo Cardona, Luis Caraballo, Carlos Serrano, Ruth Ramírez, Susana Díez, Elizabeth García, Ana María Segura, Alfonso Cepeda, María Minotas, Inmunoterapia con alérgenos: mecanismos de acción, impacto terapéutico y socioeconómico. Consenso de la Asociación Colombiana de Alergias, Asma e Inmunología , Biomédica: Vol. 36 Núm. 3 (2016)
- Ana Milena Lozano, Juan Felipe López, Josefina Zakzuk, Elizabeth García, Urticaria papular y sus agentes causales en Colombia , Biomédica: Vol. 36 Núm. 4 (2016)
- Jorge Alonso Marín, Mayra Alexandra Ortega, Isaura Pilar Sánchez, José Armando Pacheco, Síndrome de hipersensibilidad a medicamentos con exantema, eosinofilia y síntomas sistémicos inducido por carbamazepina , Biomédica: Vol. 37 Núm. 2 (2017)
Número
Sección
Presentación de caso
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
